La eficacia (no confirmada) del tratamiento dietético nutricional del Síndrome Intestino Irritable

Virginia López Bastida; Ignacio Jáuregui-Lobera

doi:10.19230/jonnpr.1600

Authors

Virginia López Bastida Instituto de Ciencias de la Conducta. Sevilla
Ignacio Jáuregui-Lobera Instituto de Ciencias de la Conducta. Sevilla Universidad Pablo de Olavide. Sevilla

DOI:

https://doi.org/10.19230/jonnpr.1600

Keywords:

Irritable Bowel Syndrome, nutrition, diet, LOW FODMAP, restriction of food, symptomatology

Abstract

Objective: our piece of work pretends to evaluate the efficacy of dietary nutritional treatment in IBS in recent years, analyze their efficacy at the individual level or as part of a multidisciplinary treatment, and describe the adverse events, in case that there are.

Methods: We searched the PubMed and Wiley Online Library databases, in which we have introduced different descriptors related to our aims and we have selected our inclusion criteria. We have collected a total of 21 articles.

Results: LOW-FODMAP, gluten-free, lactose-free and fructose-restricted diets are the nutritional interventions that most IBS patients take to alleviate their symptoms.

Conclusions:The different limitations of the studies, the considerable restriction of food as well as the possible adverse events, preclude the affirmation of the effectiveness in the nutritional treatment of IBS. There is symptomatic improvement, maybe due to the psychological component, which takes preference in these patients?

Downloads

Download data is not yet available.

References

Blanco H, Rodríguez J, Schneider R. Síndrome Intestino Irritable y otros Trastornos Relacionados. 1ªed. Madrid: Médica Panamericana; 2010. 3-30, 41-43,45-53, 81-89

Montoro MJ, Garcían JC. Gastroenterología y Hepatología: Problemas comunes en la práctica clínica. 2ª ed. Madrid: Jarpyo; 2012. 523-568

Canavan C, West J, Card, T. The epidemiology of irritable bowel syndrome. Dovepress 2014; 6: 71-80

Rey E, Tlley NJ. Irritable bowel syndrome: Novel views on the epidemiology and potential risk factors. Dig Liver Dis 2009;41(11):772- 780.

Flik C E, van Rood Y R, de Wit N Y. Systematic review: knowledge and educational needs of patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2015; 27(4):367-371.

Estremera F. Nutrient Drink Test: una nueva herramienta para el diagnóstico del síndrome del intestino irritable (Tesis Doctoral en internet).Madrid: Universidad Complutense de Madrid; 2014. 5-75.

Staudacher H M, Whelan K. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the LOW FODMAP diet. Proc Nutr Soc 2016;75(03):306- 318.

Ceuleers H, Van Spaendonk H, HanningN, Heirbaut J, Lambeir A M, Joossens J, De Winter B.Y. Inflammatory bowel diseases and irritable bowel syndrome: The role of proteases. World J Gastroenterol 2016; 22(47): 10275–10286.

Thijssen AY, Mujagic Z, Jonkers DM A E, Ludidi S, Keszthelyi D, Hesselink M, Masclee AAM. Alterations in serotonin metabolism in the irritable bowel syndrome. Aliment Pharmacol Ther 2015; 43(2): 272-282.

Makker J, Chilimuri S, Bella JN. Genetic epidemiology of irritable bowel syndrome. World J Gastroenterol 2015;21(40): 11353.

Schumlson M. Ecos del Síndrome de Intestino irritable en la DDW. Rev Gastroenterol Mex 2016;81(1):53-56

Enck P, Junne F, Klosterhalfen S, Zipfel S, Martens U. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2010; 22(12): 1402-1411.

Remes-Troche J M, Gómez-Escudero O, Nogueira-de Rojas JR, Carmona-Sánchez R, Pérez-Manauta J, López-Colombo A, González- Martínez M. Tratamiento farmacológico del síndrome de intestino irritable: revisión técnica. Rev Gastroenterol Mex 2010;75(1): 42-66.

Carmona-Sánchez R, Icaza-Chávez ME, Bielsa-Fernández M V, Gómez-Escudero O, Bosques-Padilla F, Coss-Adame E, López-Colombo A. Consenso mexicano sobre el síndrome de intestino irritable. Rev Gastroenterol Mex 2016;81(3):149-167.

Fernández Rodríguez, C. Tratamiento psicológico en el síndrome del intestino irritable. Psicothema 1989;1:1-2.

Edebol-Carlman H, Ljótsson B, Linton S J, Boersma K, Schrooten M, Repsilber D, Brummer RJ. Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms. Gastroenterology research and practice 2017;2017:1-9.

Zolezzi Francis, A. Las enfermedades funcionales gastrointestinales y Roma III. Rev Gastroenterol Peru 2007;27(2):177-184.

Espín Jaime, B. Puesta al día: trastornos funcionales digestivos en pediatría [Internet] Sevilla: Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica 2017 [citado el 28 de mayo de 2017]Disponible en : https://www.gastroinf.es/sites/default/files/files/Espin.pdf

Hookway, C., Buckner, S., Crosland, P., & Longson, D. (2015). Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance. BMJ 2015; 350.

Rodríguez-Moranta, F., Lobatón, T., Rodríguez-Alonso, L., & Guardiola, J. (2013). Calprotectina fecal en el diagnóstico de enfermedades inflamatorias. Gastroenterol Hepatol 2013; 36(6):400-406.

Piedrafita SS, Bañares, F. F. Enteropatía sensible al gluten y dispepsia funcional. Gastroenterol Hepatol 2012;35(2):78-88.

Chalaye P, Goffaux P, Bourgault P, Lafrenaye S, Devroede G, Watier A, Marchand S. Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients. Clin J Pain 2012;28(6): 519-526.

Marum A P, Moreira C, Saraiva F, Tomas-Carus P, Sousa-Guerreiro, C. A low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients. Scandinavian Journal of Pain 2016; 13: 166-172.

Staudacher HM. Lomer MC, Anderson JL, Barret JS, Muir JG, Irving PM, Whelan K.Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome. J Nutr 2012; 142(8):1510-1518.

Choi YK, Kraft N, Zimmerman B, Jackson M, Rao SC. Fructose Intolerance in IBS and Utility of Fructose-Restricted Diet. Journal of Clinical Gastroenterology 2008; 42(3):233-238.

Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled Evidence. Clin Gastroenterol Hepatol 2008; 6(7):765–77.

Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. (2014). A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome. Gastroenterology 2014;146(1):67–75.

Maagaard L, Ankersen DV, Végh Z, Burisch J, Jensen L, Pedersen N, Munkholm P. Follow-up of patients with functional bowel symptoms treated with a LOW FODMAP diet. World J Gastroenterol 2016; 22 (15):4009-4019.

Böhn N, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Simrén M.Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology 2015;149(6):1399–1407.

Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm, P. Ehealth: LOW FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014;20(43): 16215-16226.

Aziz I, Trott N, Briggs R, North JJ, Hadjivassiliou M, Sanders DS. Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome- Diarrhea Unaware of Their HLA-DQ2/8 Genotype. Clin Gastroenterol Hepatol 2016; 14(5):696–703.

Mazzawi T, Hausken T, Gundersen D, El-Salhy M. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr 2016; 70(2): 175–181.

Huamán JW, Felip A, Guedea E, Jansana M, Videla S, Saperas E. La dieta con bajo contenido en hidratos de carbono de cadena corta y polioles fermentables mejora los síntomas en pacientes con trastornos funcionales gastrointestinales en España. Gastroenterol Hepatol 2015; 38 (3): 113-122.

Rodrigo L, Blanco I, Bobes J, De Serres FJ. Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study. Arthritis Res Ther 2014; 16(24):421.

Böhmer CJM, Tuynman H. The effect of a lactose restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow up study. Eur J Gastroenterol Hepatol 2001; 13 (8):941-944.

Atkinson W, Sheldon TA, Shaath N, Whorwell, P.J. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53(10): 1459-1464.

Ong DK, Mitchel SB, Barret JS, Shepherd SJ, Irving PM, Biesiekierski JR, Smith S, Gibson PR, Muir JG. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25(8):1366–1373.

Hustoft TN, Hausken T, Ystad S O, Valeur J, Brokstad K, Hatlebakk J G, Lied GA. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil 2016; 29(4).

Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No Effects of Gluten in Patients With Self-Reported Non-Celiac Gluten Sensitivity After Dietary Reduction of Fermentable, Poorly Absorbed, Short-Chain Carbohydrates. Gastroenterology 2013; 145(2): 320–328.

Pérez López N, Torres-López E, Zamarripa-Dorsey F. Clinical response in Mexican patients with irritable bowel syndrome treated with a low diet low in fermentable carbohydrates (FODMAP). Rev Gastroenterol Mex 2015;80(3): 180-185.

Chumpitazi BP, Cope JL, Hollister EB, Tsai CM, McMeans AR, Luna RA, Versalovic J, Shulman RJ. Randomised Clinical Trial: Gut Microbiome Biomarkers are Associated with Clinical Response to a LOW FODMAP Diet in Children with Irritable Bowel Syndrome. Aliment Pharmacol Ther 2015; 42(4): 418–427.

Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Randomised clinical trial: the efficacy of gutdirected hypnotherapy is similar to that of the LOW FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44(5):447–459.

Mazzawi T, Hausken T, Gundersen D, El-Salhy M. Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Molecular Medicine Reports 2013; 8(3): 845-852.

Whigham L, Joyce T , Harper G, Irving P M, Staudacher HM, Whelan K, Lomer MCE. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (LOW FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet 2015; 28(6): 687-696.